News
DSKYF
14.96
NaN%
--
Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise
Seeking Alpha · 19h ago
Morgan Stanley Reaffirms Their Buy Rating on Daiichi Sankyo Company (DSKYF)
TipRanks · 22h ago
J.P. Morgan Sticks to Its Hold Rating for Daiichi Sankyo Company (DSKYF)
TipRanks · 2d ago
Bernstein Sticks to Its Buy Rating for Daiichi Sankyo Company (DSKYF)
TipRanks · 3d ago
Weekly Report: what happened at DSKYF last week (0525-0529)?
Weekly Report · 5d ago
SMBC Nikko Remains a Buy on Daiichi Sankyo Company (DSKYF)
TipRanks · 05/27 10:39
Daiichi Sankyo Company (DSKYF) Receives a Buy from Mizuho Securities
TipRanks · 05/27 10:33
UBS Reaffirms Their Hold Rating on Daiichi Sankyo Company (DSKYF)
TipRanks · 05/25 12:30
Weekly Report: what happened at DSKYF last week (0518-0522)?
Weekly Report · 05/25 09:09
AstraZeneca gains approval of Datroway as a first-line breast cancer treatment
Seeking Alpha · 05/22 15:18
AbbVie, Merck, Astra among winners of EU drug recommendations this week
Seeking Alpha · 05/22 14:56
Daiichi Sankyo Company (DSKYF) Receives a Buy from Citi
TipRanks · 05/18 10:05
Weekly Report: what happened at DSKYF last week (0511-0515)?
Weekly Report · 05/18 09:09
AZN :FDA Approves ENHERTU For HER2-Positive Early Breast Cancer In Neoadjuvant And Adjuvant Settings
NASDAQ · 05/17 15:49
Daiichi Sankyo Corrects FY2025 Presentation Materials Without Changing Financial Results
TipRanks · 05/13 10:02
Daiichi Sankyo Company (DSKYF) Gets a Buy from Macquarie
TipRanks · 05/12 10:31
Daiichi Sankyo GAAP EPS of ¥140.44, revenue of ¥2.12B
Seeking Alpha · 05/11 12:59
Weekly Report: what happened at DSKYF last week (0504-0508)?
Weekly Report · 05/11 09:09
Daiichi Sankyo Publishes Detailed FY2025 Consolidated Financial Data
TipRanks · 05/11 07:18
Daiichi Sankyo lifts dividend as profit dips on non-recurring factors
TipRanks · 05/11 07:17
More
Webull provides a variety of real-time DSKYF stock news. You can receive the latest news about Daiichi Sankyo through multiple platforms. This information may help you make smarter investment decisions.
About DSKYF
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.